Neuphoria Therapeutics Inc (NEUP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2023 | 12-2022 | 06-2022 | 06-2021 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 12,103 | 20,190 | 24,351 | 21,295 |
| Marketable Securities | 0 | N/A | 0 | 326 |
| Receivables | 426 | 112 | 4,922 | 843 |
| Other current assets | 798 | 1,501 | 1,060 | 645 |
| TOTAL | $13,327 | $21,803 | $30,333 | $23,109 |
| Non-Current Assets | ||||
| PPE Net | 48 | N/A | 52 | 80 |
| Investments And Advances | 80 | 78 | 86 | 89 |
| Other Non-Current Assets | 15,004 | 14,765 | 16,473 | 16,697 |
| TOTAL | $15,132 | $14,843 | $16,612 | $16,866 |
| Total Assets | $28,563 | $37,033 | $47,383 | $40,546 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 2,357 | 2,033 | 2,021 | 1,356 |
| Other current liabilities | 308 | 266 | 297 | 278 |
| TOTAL | $2,739 | $2,408 | $2,435 | $1,764 |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 2,497 | 1,812 | 1,966 | 1,322 |
| TOTAL | $3,855 | $3,240 | $3,658 | $3,217 |
| Total Liabilities | $6,552 | $5,648 | $6,092 | $4,981 |
| Shareholders' Equity | ||||
| Common Shares | 150,401 | 146,997 | 157,938 | 142,110 |
| Retained earnings | -162,485 | -124,456 | -125,734 | -115,099 |
| Other shareholders' equity | 34,095 | 8,844 | 9,086 | 8,554 |
| TOTAL | $22,011 | $31,385 | $41,290 | $35,565 |
| Total Liabilities And Equity | $28,563 | $37,033 | $47,382 | $40,546 |